Phase III Trial of Targeted Intra-arterial Gemcitabine vs. Continuation of IV Gemcitabine Plus Nab-Paclitaxel Following Induction With Sequential IV Gemcitabine Plus Nab-Paclitaxel and Radiotherapy for Locally Advanced Pancreatic Cancer (TIGeR-PaC)
The purpose of this phase III study is to evaluate the efficacy of of intra-arterial chemotherapy with gemcitabine vs. IV gemcitabine plus nab-paclitaxel among patients with locally advanced pancreatic adenocarcinoma which is unresectable.
Study ID: RR3
Trial Phase: Phase III
Trial Sponsor: RenovoRx
Therapies Used in This Trial: Nab-paclitaxel, Gemcitabine, Radiation Therapy, Capecitabine